CRL vs TOL · rev $2.00B vs P/E 11, rev $7.34B
Charles River Laboratories (CRL) versus Toll Brothers Inc (TOL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Toll Brothers Inc (TOL) is a residential construction company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported TOL revenue for 2026-07-31 was $7.34B. Net income was $751.7M. Revenue was up 56.8% from 2026-04-30 to 2026-07-31. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
CRL currently screens at market cap $7.78B. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
Not investment advice. Open the CRL and TOL stock pages for the full models.
Not investment advice.